{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:30:33Z","timestamp":1790857833837,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["2025ZZTS0152"],"award-info":[{"award-number":["2025ZZTS0152"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ30891"],"award-info":[{"award-number":["2023JJ30891"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373960"],"award-info":[{"award-number":["82373960"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-025-00766-y","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:43:14Z","timestamp":1752507794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gut bacteria and the host synergies promote resveratrol metabolism and induce tolerance in ALD mice"],"prefix":"10.1038","volume":"11","author":[{"given":"Song-xia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-fang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-wen","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-ling","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie-lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-hui","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"766_CR1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3350\/cmh.2020.0203","volume":"26","author":"M Taniai","year":"2020","unstructured":"Taniai, M. Alcohol and hepatocarcinogenesis. Clin. Mol. Hepatol. 26, 736\u2013741 (2020).","journal-title":"Clin. Mol. Hepatol."},{"key":"766_CR2","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1001\/jama.2022.4308","volume":"327","author":"AM White","year":"2022","unstructured":"White, A. M. et al. Alcohol-related deaths during the COVID-19 pandemic. JAMA 327, 1704\u20131706 (2022).","journal-title":"JAMA"},{"key":"766_CR3","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","volume":"21","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global burden of liver disease. Clin. Gastroenterol. Hepatol. 21, 1978\u20131991 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"766_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ajg.2017.469","volume":"113","author":"AK Singal","year":"2018","unstructured":"Singal, A. K. et al. ACG clinical guideline: alcoholic liver disease. Am. J. Gastroenterol. 113, 175\u2013194 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"766_CR5","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s40265-023-01939-9","volume":"83","author":"DS Prince","year":"2023","unstructured":"Prince, D. S., Nash, E. & Liu, K. Alcohol-associated liver disease: evolving concepts and treatments. Drugs 83, 1459\u20131474 (2023).","journal-title":"Drugs"},{"key":"766_CR6","doi-asserted-by":"publisher","first-page":"112164","DOI":"10.1016\/j.biopha.2021.112164","volume":"143","author":"LX Zhang","year":"2021","unstructured":"Zhang, L. X. et al. Resveratrol (RV): a pharmacological review and call for further research. Biomed. Pharmacother. 143, 112164 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"766_CR7","doi-asserted-by":"publisher","first-page":"9932218","DOI":"10.1155\/2021\/9932218","volume":"2021","author":"DD Zhou","year":"2021","unstructured":"Zhou, D. D. et al. Effects and mechanisms of resveratrol on aging and age-related diseases. Oxid. Med. Cell Longev. 2021, 9932218 (2021).","journal-title":"Oxid. Med. Cell Longev."},{"key":"766_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/molecules26010229","volume":"26","author":"T Meng","year":"2021","unstructured":"Meng, T. et al. Anti-inflammatory action and mechanisms of resveratrol. Molecules 26, 229 (2021).","journal-title":"Molecules"},{"key":"766_CR9","doi-asserted-by":"publisher","first-page":"107037","DOI":"10.1016\/j.phrs.2023.107037","volume":"199","author":"S Shen","year":"2024","unstructured":"Shen, S. et al. SIRT1\/SREBPs-mediated regulation of lipid metabolism. Pharm. Res. 199, 107037 (2024).","journal-title":"Pharm. Res."},{"key":"766_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.biopha.2018.02.063","volume":"101","author":"T Szkudelski","year":"2018","unstructured":"Szkudelski, T. & Szkudelska, K. Potential of resveratrol in mitigating metabolic disturbances induced by ethanol. Biomed. Pharmacother. 101, 579\u2013584 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"766_CR11","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1142\/S0192415X16500671","volume":"44","author":"L Tang","year":"2016","unstructured":"Tang, L. et al. Resveratrol ameliorates alcoholic fatty liver by inducing autophagy. Am. J. Chin. Med. 44, 1207\u20131220 (2016).","journal-title":"Am. J. Chin. Med."},{"key":"766_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","volume":"18","author":"X Wu","year":"2023","unstructured":"Wu, X. et al. Recent advances in understanding of pathogenesis of alcohol-associated liver disease. Annu. Rev. Pathol. 18, 411\u2013438 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"766_CR13","doi-asserted-by":"publisher","first-page":"G833","DOI":"10.1152\/ajpgi.90358.2008","volume":"295","author":"JM Ajmo","year":"2008","unstructured":"Ajmo, J. M. et al. Resveratrol alleviates alcoholic fatty liver in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G833\u2013G842 (2008).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"766_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3945\/ajcn.112.049379","volume":"97","author":"LM Bode","year":"2013","unstructured":"Bode, L. M. et al. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am. J. Clin. Nutr. 97, 295\u2013309 (2013).","journal-title":"Am. J. Clin. Nutr."},{"key":"766_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40199-023-00458-y","volume":"31","author":"H Shamardl","year":"2023","unstructured":"Shamardl, H. et al. Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: role of SIRT-1\/adipokines\/PPAR\u03b3 and IGF-1. Daru 31, 13\u201327 (2023).","journal-title":"Daru"},{"key":"766_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","volume":"18","author":"R Wang","year":"2021","unstructured":"Wang, R. et al. Gut microbiome, liver immunology, and liver diseases. Cell Mol. Immunol. 18, 4\u201317 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"766_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel, S. P. et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat. Commun. 10, 310 (2019).","journal-title":"Nat. Commun."},{"key":"766_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1089\/sur.2017.245","volume":"19","author":"STK Yauw","year":"2018","unstructured":"Yauw, S. T. K. et al. Microbial glucuronidase inhibition reduces severity of diclofenac-induced anastomotic leak in rats. Surg. Infect. 19, 417\u2013423 (2018).","journal-title":"Surg. Infect."},{"key":"766_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2019.03.002","volume":"199","author":"AN Chamseddine","year":"2019","unstructured":"Chamseddine, A. N. et al. Intestinal bacterial \u03b2-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity. Pharm. Ther. 199, 1\u201315 (2019).","journal-title":"Pharm. Ther."},{"key":"766_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-017-0034-1","volume":"3","author":"L Guthrie","year":"2017","unstructured":"Guthrie, L. et al. Human microbiome signatures of differential colorectal cancer drug metabolism. NPJ Biofilms Microbiomes 3, 27 (2017).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"766_CR21","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/art.41622","volume":"73","author":"A Artacho","year":"2021","unstructured":"Artacho, A. et al. The pretreatment gut microbiome is associated with lack of response to methotrexate in new-onset rheumatoid arthritis. Arthritis Rheumatol. 73, 931\u2013942 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"766_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/alcalc\/agz103","volume":"55","author":"CL Haass-Koffler","year":"2020","unstructured":"Haass-Koffler, C. L. & Perciballi, R. Alcohol tolerance in human laboratory studies for development of medications to treat alcohol use disorder. Alcohol Alcohol 55, 129\u2013135 (2020).","journal-title":"Alcohol Alcohol"},{"key":"766_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/17425255.2018.1482276","volume":"14","author":"KCE Rocha","year":"2018","unstructured":"Rocha, K. C. E., Pereira, B. M. V. & Rodrigues, A. C. An update on efflux and uptake transporters as determinants of statin response. Expert Opin. Drug Metab. Toxicol. 14, 613\u2013624 (2018).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"766_CR24","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s40262-021-01032-y","volume":"60","author":"SM Tsunoda","year":"2021","unstructured":"Tsunoda, S. M. et al. Contribution of the gut microbiome to drug disposition, pharmacokinetic and pharmacodynamic variability. Clin. Pharmacokinet. 60, 971\u2013984 (2021).","journal-title":"Clin. Pharmacokinet."},{"key":"766_CR25","doi-asserted-by":"publisher","first-page":"eaat9931","DOI":"10.1126\/science.aat9931","volume":"363","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann, M. et al. Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science 363, eaat9931 (2019).","journal-title":"Science"},{"key":"766_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ecco-jcc\/jjaa143","volume":"15","author":"F Crouwel","year":"2020","unstructured":"Crouwel, F., Buiter, H. J. C. & de Boer, N. K. Gut microbiota-driven drug metabolism in inflammatory bowel disease. J. Crohns Colitis 15, 307\u2013315 (2020).","journal-title":"J. Crohns Colitis"},{"key":"766_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55\u201371 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"766_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41579-022-00681-5","volume":"20","author":"AE Lindell","year":"2022","unstructured":"Lindell, A. E., Zimmermann-Kogadeeva, M. & Patil, K. R. Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota. Nat. Rev. Microbiol. 20, 431\u2013443 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"766_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-020-2269-x","volume":"581","author":"S Vieira-Silva","year":"2020","unstructured":"Vieira-Silva, S. et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature 581, 310\u2013315 (2020).","journal-title":"Nature"},{"key":"766_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/03602532.2023.2197178","volume":"55","author":"DH Kim","year":"2023","unstructured":"Kim, D. H. Interaction of drugs with gut microbiota modulators. Drug Metab. Rev. 55, 181\u2013194 (2023).","journal-title":"Drug Metab. Rev."},{"key":"766_CR31","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.apsb.2020.09.013","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm. Sin. B 11, 1789\u20131812 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"766_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.1235872","volume":"341","author":"HJ Haiser","year":"2013","unstructured":"Haiser, H. J. et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341, 295\u2013298 (2013).","journal-title":"Science"},{"key":"766_CR33","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1172\/JCI72335","volume":"124","author":"RN Carmody","year":"2014","unstructured":"Carmody, R. N. & Turnbaugh, P. J. Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J. Clin. Invest. 124, 4173\u20134181 (2014).","journal-title":"J. Clin. Invest."},{"key":"766_CR34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nprot.2013.032","volume":"8","author":"A Bertola","year":"2013","unstructured":"Bertola, A. et al. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat. Protoc. 8, 627\u2013637 (2013).","journal-title":"Nat. Protoc."},{"key":"766_CR35","doi-asserted-by":"publisher","first-page":"5952436","DOI":"10.1155\/2022\/5952436","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. A joint technology combining the advantages of capillary microsampling with mass spectrometry applied to the trans-resveratrol pharmacokinetic study in mice. J. Anal. Methods Chem. 2022, 5952436 (2022).","journal-title":"J. Anal. Methods Chem."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00766-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00766-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00766-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:13:17Z","timestamp":1757236397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00766-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1038\/s41522-025-00766-y","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"15 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}